62
2
Cat. No. | Product Name | Target | Signaling Pathways |
---|---|---|---|
T2355 |
CFTR(inh)-172
CFTRinh 172,CFTR Inhibitor-172,CFTRinh-172,CFTRinh172 |
CFTR; Autophagy | Autophagy; Membrane transporter/Ion channel |
CFTR(inh)-172 (CFTR Inhibitor-172) 是一种不依赖电压的选择性 CFTR 抑制剂,在2分钟内可逆地抑制CFTR 短路电流的Ki 值为300 nM。 | |||
T10776 |
CFTR corrector 4
|
CFTR | Membrane transporter/Ion channel |
CFTR corrector 4是一种高效且可口服的囊性纤维化跨膜电导调节剂 (CFTR),是一种有效的 (R,R) 型活性对映体。CFTR corrector 4 可以增加细胞表面的 CFTR 水平,是用来研究囊性纤维化的潜在化合物。 | |||
T5312 |
CFTR corrector 2
FDL169 |
CFTR; Autophagy | Autophagy; Membrane transporter/Ion channel |
CFTR corrector 2 (FDL169) 是一种新型有效的囊性纤维化跨膜电导调节因子(CFTR)调节剂,用于治疗携带 F508del 突变的囊性纤维化患者。 | |||
T63806 |
CFTR corrector 8
|
CFTR | Membrane transporter/Ion channel |
CFTR corrector 8 is a highly effective modulator of the cystic fibrosis transmembrane conductance regulator (CFTR). This compound is specifically designed for utilization in research related to cystic fibrosis, a genetic disorder primarily affecting the lungs and digestive system [1]. | |||
T1874 |
PPQ-102
PPQ102,CFTR Inhibitor,PPQ 102 |
CFTR; Autophagy | Autophagy; Membrane transporter/Ion channel |
PPQ-102 (CFTR Inhibitor) 是一种CFTR 抑制剂,可以完全抑制CFTR 氯化物电流,IC50为90 nM。 | |||
T60653 |
CFTR corrector 9
|
CFTR | Membrane transporter/Ion channel |
CFTR corrector 9是一种囊性纤维化跨膜传导调节蛋白 (CFTR)调节剂。CFTR corrector 9 可用于研究囊性纤维化 (CF) 和其他 CFTR 相关疾病。 | |||
T37686 |
CFTR corrector 6
|
||
CFTR corrector 6 is a highly effective CFTR potentiator utilized in research on cystic fibrosis (CF) and related CFTR-associated disorders[1]. This potent compound exhibits potentiation activity on the Cystic Fibrosis Transmembrane conductance Regulator (CFTR), rendering it beneficial for investigations in CF and other associated conditions. | |||
T79578 |
CFTR corrector 12
|
CFTR | Membrane transporter/Ion channel |
CFTRcorrector 12(compound 17C)作为一种双噻唑衍生物,本身是CFTR校正剂。它具有校正控制氯离子跨膜运输通道的特定折叠缺陷突变的功能,并能够在带有突变的细胞中恢复α-肌聚糖(α-SG)的含量。 | |||
T2451 |
GlyH-101
GlyH 101 |
CFTR; Autophagy | Autophagy; Membrane transporter/Ion channel |
GlyH-101 是一种可渗透入细胞的 CFTR 阻断剂,Ki 为1.4 uM。 | |||
T3135 |
KM11060
|
CFTR; Autophagy | Autophagy; Membrane transporter/Ion channel |
KM11060 是 F508del-CFTR 运输缺陷的新型校正剂,可纠正 F508del-CFTR 运输,增加质膜上功能性 CFTR 的数量。它可用于 F508del-CFTR 加工缺陷的研究和囊性纤维化治疗剂的开发。 | |||
T1805 |
Ataluren
PTC124 |
CFTR; Autophagy | Autophagy; Membrane transporter/Ion channel |
Ataluren (PTC124) 是一种可口服的 CFTR-G542X 无义等位基因抑制剂。 | |||
T14935 |
Elexacaftor
VX-445 |
CFTR; Autophagy | Autophagy; Membrane transporter/Ion channel |
Elexacaftor (VX-445) 是一种囊性纤维化跨膜电导调节因子 (CFTR) 校正剂。它促进CFTR 的加工和转运,增加细胞表面CFTR 的数量。 | |||
T16681 |
Nesolicaftor
PTI-428 |
CFTR; Autophagy | Autophagy; Membrane transporter/Ion channel |
Nesolicaftor (PTI-428) 特异性增强囊性纤维化跨膜电导调节蛋白合成。 | |||
T9499 |
Icenticaftor
QBW251 |
CFTR | Membrane transporter/Ion channel |
Icenticaftor (QBW251) 是一种具有口服活性CFTR 通道增强剂,可用于慢性阻塞性肺疾病 (COPD) 和囊性纤维化研究,对F508del 和G551D CFTR 的EC50分别为 79 和 497 nM。 | |||
T7083 |
GLPG1837
ABBV-974 |
CFTR; Autophagy | Autophagy; Membrane transporter/Ion channel |
GLPG1837 (ABBV-974) 是一种有效的 CFTR 增强剂,对其 F508del 和 G551D 的 EC50 分别为 3 nM 和 339 nM。 | |||
T2588 |
Ivacaftor
Ivacaftor (VX-770),VX-770,依伐卡托 |
CFTR; Autophagy | Autophagy; Membrane transporter/Ion channel |
Ivacaftor (VX-770) 是一种 CFTR 增强剂,靶向G551D-CFTR 和F508del-CFTR 的EC50分别为100 和 25 nM。 | |||
T10591 |
BPO-27 racemate
BPO-27 (racemate) |
CFTR; Autophagy | Autophagy; Membrane transporter/Ion channel |
BPO-27 racemate (BPO-27(racemate)) 是一种CFTR 抑制剂,IC50为8 nM。 | |||
T2486 |
IOWH-032
IOWH032,IOWH 032 |
CFTR; Autophagy | Autophagy; Membrane transporter/Ion channel |
IOWH-032 (IOWH032) 是一种合成 CFTR 抑制剂,可用于研究治疗霍乱、腹泻和分泌性腹泻,在T84和CHO-CFTR 细胞实验中IC50为1.01 uM。 | |||
T2595 |
Lumacaftor
鲁玛卡托,VX-809,VRT 826809 |
CFTR; Autophagy | Autophagy; Membrane transporter/Ion channel |
Lumacaftor (VRT 826809) 是一种 CFTR 调节剂,可纠正 CFTR 蛋白的折叠和运输。它增强了 FRT 细胞中 F508del-CFTR 蛋白的成熟,EC50为100 nM。 | |||
T1634 |
Glibenclamide
格列本脲,Glyburide |
Potassium Channel; Mitochondrial Metabolism; CFTR; P-gp; Autophagy | Autophagy; Membrane transporter/Ion channel; Metabolism; Neuroscience |
Glibenclamide (Glyburide) 是一种具有口服活性的 ATP 敏感的 K+通道抑制剂,可研究糖尿病和肥胖。它抑制 P-糖蛋白,可直接结合并阻断 KATP 的 SUR1亚基并抑制囊性纤维化跨膜传导调节蛋白。它通过诱导膜离子通透性干扰线粒体生物能,可诱导自噬。 | |||
T2263 |
Tezacaftor
VX661,1-(2,2-二氟-1,3-苯并二氧戊环-5-基)-N-[1-[(2R)-2,3-二羟基丙基]-6-氟-2-(2-羟基-1,1-二甲基乙基)-1H-吲哚-5-基]-环丙烷甲酰胺 |
CFTR; Autophagy | Autophagy; Membrane transporter/Ion channel |
Tezacaftor (VX661) 是一种小分子,可用作囊性纤维化跨膜电导调节器基因功能的校正剂。 | |||
T16516 |
PG01
Phenylglycine-01 |
CFTR | Membrane transporter/Ion channel |
PG01是一种有效的CFTR Cl-通道增效剂,PG01对 ΔF508(Ka 为 0.3 μM)有效。PG01 对 E193K,G970R 和 G551D (CFTR 突变体)也 有效,Kd 值分别为 0.22 μM,0.45 μM 和 1.94 μM 。PG01在加入Forskolin 后可增加ΔF508-CFTR Cl-电流,纠正CFTR 突变体的门控缺陷。 | |||
T10591L |
(R)-BPO-27
|
CFTR; Autophagy | Autophagy; Membrane transporter/Ion channel |
(R)-BPO-27 是一种具有口服活性和高效性的 ATP 竞争性 CFTR 抑制剂(IC50:4 nM),可用于研究腹泻和多囊肾。 | |||
T30293 |
Bamocaftor
VX-659 |
CFTR | Membrane transporter/Ion channel |
Bamocaftor是一种CFTR通道(DeltaF508-CFTR突变)矫正器,适用于 CF 跨膜传导调节器,被设计用于恢复 F508del-CFTR 蛋白功能。联合使用 tezacaftor 和 VX-561 治疗 F508del/MF 的囊性纤维化患者。 | |||
T20341 |
DNDS
|
CFTR | Membrane transporter/Ion channel |
DNDS 是电压依赖性囊性纤维化跨膜电导调节剂 (CFTR) 的通道阻滞剂。 | |||
T29041 |
UCCF-853
UCCF853,UCCF 853 |
CFTR | Membrane transporter/Ion channel |
UCCF-853 是一种小分子 CFTR 调节剂,可用于研究囊性纤维化。 | |||
T29114 |
VRT-532
CFpot-532,CFpot-532) |
CFTR | Membrane transporter/Ion channel |
VRT-532 (CFpot-532)是CFTR 的有效调节剂,常用于CFTR 缺陷引起的囊性纤维化(CF)研究。降解囊性纤维化中积累的硫酸化糖胺聚糖(gag)所必需的Arylsulfatase B (ARSB),小分子调节剂VRT-532对CFTR 的修饰能增加ARSB 并减少4-硫酸软骨素的积累。 | |||
T26955 |
Cavosonstat
N91115,N 91115,N-91115 |
GSNOR; CFTR | Membrane transporter/Ion channel; Metabolism |
Cavosonstat (N91115) 是一种口服活性 S-亚硝基谷胱甘肽还原酶(GSNOR)抑制剂,可促进囊性纤维化跨膜传导调节器(CFTR)成熟和质膜稳定。 | |||
T31014 |
Corrector C4
Corr 4a,Corrector C-4,Corr4a,Corrector C 4,Corr-4a |
Others | Others |
Corrector C4 是一种常用于研究囊性纤维化突变体的校正子,通过减轻CFTR跨膜结构域突变体与蛋白稳态的相互作用来发挥作用。 | |||
T77604 |
WAY-326766
|
CFTR | Membrane transporter/Ion channel |
WAY-326766通过突变型 CFTR 增加离子转运,可用于改变真核生物的寿命。WAY-326766可用于治疗囊性纤维化(CF)。 | |||
T39596 |
Dirocaftor
PTI-808 |
||
Dirocaftor (PTI-808) is a CFTR potentiator that augments CFTR protein function via the activation of chloride channels. Dirocaftor holds potential utility for research pertaining to cystic fibrosis (CF). | |||
T13705 | GLPG2451 | Cysteine Protease | Proteases/Proteasome |
GLPG2451 is a cystic fibrosis transmembrane conductance regulator (CFTR) potentiator. It effectively potentiates low temperature rescued F508del CFTR (EC50: 11.1 nM). | |||
T40386 |
CP-628006
|
||
CP-628006 is a small molecule CFTR potentiator that effectively restores ATP-dependent channel gating to G551D-CFTR, the mutant form found in cystic fibrosis. | |||
T36519 |
Posenacaftor sodium
|
||
Posenacaftor (PTI-801) sodium, a cystic fibrosis transmembrane regulator (CFTR) modulator, corrects CFTR protein folding and trafficking. It is utilized in researching cystic fibrosis (CF)[1]. | |||
T35925 |
(R)-Posenacaftor sodium
|
||
(R)-Posenacaftor ((R)-PTI-801) sodium, the R enantiomer of Posenacaftor, is a cystic fibrosis transmembrane regulator (CFTR) protein modulator. It corrects the folding and trafficking of the CFTR protein, and is utilized in the research of cystic fibrosis (CF)[1]. | |||
T29040 |
UCCF-029
UC(CF)-029,UC(CF) 029,UCCF029,UC(CF)029 |
||
UCCF-029 is an activator of cystic fibrosis transmembrane conductance regulator (CFTR). | |||
T22252 |
Galicaftor
|
Others | Others |
ABBV-2222 is a CFTR corrector which is studied for the treatment of cystic fibrosis (CF). | |||
T61702 | SRI-37240 | ||
SRI-37240 is a powerful inhibitor of premature termination codons (PTCs). It effectively suppresses CFTR nonsense mutations and induces changes in cellular translation termination at PTCs in HEK293T cells. Additionally, when combined with G418, SRI-37240 restores CFTR function in primary bronchial epithelial cells [1]. | |||
T62630 |
Posenacaftor
|
||
Posenacaftor (PTI-801) 是一种囊性纤维化跨膜调节蛋白 (CFTR) 调节剂,可纠正 CFTR 蛋白的折叠和运输。Posenacaftor 能够用于研究囊性纤维化 (CF) 。 | |||
T25898 |
Olacaftor
VX 440,VX-440,VX440 |
||
Olacaftor, also known as VX-440, is a protein modulator of cystic fibrosis transmembrane regulator (CFTR). | |||
T13742 |
Ivacaftor benzenesulfonate
VX-770 benzenesulfonate |
Others | Others |
Ivacaftor benzenesulfonate used for cystic fibrosis treatment. is an orally bioavailable CFTR potentiator. | |||
T78240 |
(R)-Elexacaftor
(R)-VX-445 |
CFTR | Membrane transporter/Ion channel |
(R)-Elexacaftor,Elexacaftor (Compound 1) 的对映异构体,为囊性纤维化跨膜电导调节因子(CFTR)校正剂,其针对CFTR dF508突变体的EC50值为0.29 uM。 | |||
T13742L |
Ivacaftor hydrate
VX-770 hydrate |
Others | Others |
Ivacaftor hydrate is an orally bioavailable CFTR potentiator. It also is used for cystic fibrosis treatment. | |||
T19788 |
Piretanide
Eurelix,Tauliz,Arelix |
||
Piretanide is a time- and voltage-dependent blocker of CFTR Cl(-) currents. Piretanide also acts as a loop diuretic. | |||
T74417 | Vanzacaftor | ||
Vanzacaftor 是一种囊性纤维化跨膜电导调节体(CFTR)的调节剂,用于研究囊性纤维化。 | |||
T27098 |
Ivacaftor-D9
deutivacaftor,CTP-656 |
||
CTP-656, a cystic fibrosis transmembrane conductance regulator (CFTR) channel activator, is used potentially for the treatment of cystic fibrosis. | |||
T74748 | Zatonacaftor | ||
Zatonacaftor 是囊性纤维化跨膜调节剂(CFTR)蛋白的调节剂,主要应用于囊性纤维化的研究。 | |||
T39633 |
Navocaftor
GLPG 3067,ABBV-3067 |
||
Navocaftor, as a cystic fibrosis transmembrane regulator ( CFTR ), is a protein modulator (US 20200377491 Al, example 1). | |||
T72860 |
(R)-Olacaftor
(R)-VX-440 |
||
(R)-Olacaftor ((R)-VX-440),一种对囊性纤维化 (CF) 具有研究潜力的囊性纤维化跨膜调节因子 (CFTR) 调节剂。 | |||
T69658 | Ethyl-3,4-dephostatin | ||
Ethyl-3,4-dephostatin is a novel inhibitor of the interactions of CFTR-associated ligand and PSD-95/Dlg1/ZO-1 domain. |
Cat. No. | Product Name | Target | Signaling Pathways |
---|---|---|---|
T2S1837 |
Steviol
甜菊醇,NSC 226902,Hydroxydehydrostevic acid |
Others | Others |
Steviol (NSC-226902) 是一种甜菊糖甙的主要代谢物。它能降低 AQP2 的表达,并促进 AQP2 的降解,从而减缓肾囊肿的生长。 | |||
TN1834 |
Kobusin
去甲槟郎碱,自旋七叶素 |
Others; NOS; NF-κB | Immunology/Inflammation; NF-κB; Others |
Kobusin, a Calmodulin inhibitor, shows mild antiplasmodial,anti-inflammatory, and cytotoxic activities; it may be beneficial for the treatment of neuro-inflammatory diseases through the inhibition of iNOS expression and peroxynitrite scavenging potential. Kobusin can mildly reduce gastrointestinal motility in mice, it activates CFTR and CaCCgie chloride channel activities in mouse colonic epithelia and shows inhibitory effects toward ANO1/CaCC-mediated short-circuit currents in ANO1/CaCC-express... |